Immuno-Biological Laboratories Co., Ltd.
株式会社免疫生物研究所
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4570
FY2025 · 2026-03-31
| Gross margin | 70.4% |
| Operating margin | 28.0% |
| Net margin | 32.7% |
| Return on equity | 17.8% |
| Return on assets | 15.3% |
| Revenue growth (YoY) | 3.7% |
| EPS (basic) | ¥35.33 |
| EPS growth (YoY) | 32.1% |
| Current ratio | 5.68x |
| Equity ratio | 85.5% |
| Book value / share | ¥197.93 |
| Free cash flow | 268 M |